QA: Allarity Therapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001860657_2025_Allarity_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001860657, Allarity Therapeutics Inc

  xvar xval
0 AssetsCurrent 22,341,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 309,000
3 remainder_Assets 0
4 LiabilitiesCurrent 10,839,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,442,000
9 ResearchAndDevelopmentExpense 6,096,000
10 remainder_Expenses 9,322,000
11 remainder_Revenues 0
12 remainder_NetIncome 2,345,000
13 remainder_ComprehensiveNetIncome 57,000
  yvar yval
0 Assets 22,650,000
1 Liabilities 10,839,000
2 Expenses 26,860,000
3 Revenues 0
4 StockholdersEquity 11,811,000
5 NetIncome -24,515,000
6 ComprehensiveNetIncome -24,486,500
7 BaseVar 31,375,500
8 EconomicCapitalRatiobeforeLimitedLiability 0.0753
9 EconomicCapitalRatio 1.49

Edgar->Model Mapping

Feature Distribution

Change over Time